Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
DRUGNAME | PT | EventCount |
---|---|---|
GEMCITABINE | Neoplasm | 2 |
GEMCITABINE | Nocturia | 2 |
GEMCITABINE | Obstruction gastric | 2 |
GEMCITABINE | Ocular vascular disorder | 2 |
GEMCITABINE | Pancreatic mass | 2 |
GEMCITABINE | Peripheral motor neuropathy | 2 |
GEMCITABINE | Petechiae | 2 |
GEMCITABINE | Platelet count increased | 2 |
GEMCITABINE | Pulmonary toxicity | 2 |
GEMCITABINE | Purpura | 2 |
GEMCITABINE | Retinal vein occlusion | 2 |
GEMCITABINE | Right ventricular failure | 2 |
GEMCITABINE | Second primary malignancy | 2 |
GEMCITABINE | Splenic infarction | 2 |
GEMCITABINE | Therapy partial responder | 2 |
GEMCITABINE | Tricuspid valve incompetence | 2 |
GEMCITABINE | Vaccine virus shedding | 2 |
GEMCITABINE | Visceral venous thrombosis | 2 |
GEMCITABINE | Vulvovaginitis | 2 |
GEMCITABINE | Weight increased | 2 |
Total Records: 1,060 Number of Pages: 53